Bausch & Lomb, Alcon settle on ocular vitamins
from Reuters:
On March 18, Bausch & Lomb disclosed a settlement with Alcon concerning litigation over ocular vitamins and said the agreement sets up a cross-licensing relationship that allows Alcon to continue selling the previously disputed AREDS-based dietary supplement for the eyes, while granting Bausch & Lomb global rights under one or more of Alcon's patents.
On March 18, Bausch & Lomb disclosed a settlement with Alcon concerning litigation over ocular vitamins and said the agreement sets up a cross-licensing relationship that allows Alcon to continue selling the previously disputed AREDS-based dietary supplement for the eyes, while granting Bausch & Lomb global rights under one or more of Alcon's patents.
posted by Lawrence B. Ebert at 6:48 PM
0 Comments:
Post a Comment
<< Home